TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR
Possibilities of angina pectoris pharmacotherapy are analyzed. Achievement of target heart rate (HR) 55-60 beats per minute in these patients is possible due to three classes of antianginal medications that slow down HR: beta blockers (BB), If-channel inhibitors, nondihydropyridine calcium channel b...
Saved in:
| Main Author: | I. M. Sokolov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/809 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01) -
Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
by: V. V. Kashtalap, et al.
Published: (2019-11-01) -
Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01) -
Impact of Medications for Stable Angina Pectoris on Osteoporosis: A Review of Current Evidence
by: Wang RA, et al.
Published: (2025-07-01) -
Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis
by: Liyuan Yu, et al.
Published: (2024-10-01)